Circle Pharma Appoints Alan Ashworth, PhD, FRS and Bruce Stillman, PhD, FRS to Its SAB Epsilon09242023-07-19T07:06:48-07:00October 21, 2020|Press Releases|
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Epsilon09242023-07-19T07:07:12-07:00July 20, 2020|Press Releases|
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board Epsilon09242023-07-19T07:07:46-07:00May 27, 2020|Press Releases|
Circle Pharma raises $45 Million in Series B Financing Epsilon09242023-07-19T07:08:40-07:00March 17, 2020|Press Releases|
Circle Pharma Congratulates Dr. William G. Kaelin, Jr., MD on Award of Nobel Prize Epsilon09242023-07-19T07:09:38-07:00October 9, 2019|Press Releases|
Peptide Therapeutics Near the Sweetest Spots Epsilon09242018-04-01T19:20:09-07:00April 1, 2018|In the News|
Circle Pharma’s work with Pfizer yields new macrocyclic peptides Epsilon09242018-01-19T10:10:53-08:00January 19, 2018|In the News|
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc. Epsilon09242023-07-19T07:10:06-07:00January 17, 2018|Press Releases|
Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer Epsilon09242023-07-19T07:10:34-07:00November 20, 2017|Press Releases|
Practical Medicinal Chemistry with Macrocycles – Design, Synthesis, and Case Studies Epsilon09242017-10-18T17:53:45-07:00October 18, 2017|Publications|
